The mosaic of addiction.
Charles P
CP
O'Brien
D000077443:Acamprosate; D000427:Alcohol Deterrents / Q000494:pharmacology / Q000627:therapeutic use; D000428:Alcohol Drinking / Q000503:physiopathology / Q000523:psychology; D000437:Alcoholism / Q000188:drug therapy / Q000503:physiopathology* / Q000517:prevention & control; D016739:Behavior, Addictive / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D004195:Disease Models, Animal; D004723:Endorphins / Q000187:drug effects / Q000502:physiology; D000431:Ethanol / Q000494:pharmacology; D005059:Euphoria / Q000187:drug effects; D006801:Humans; D009271:Naltrexone / Q000494:pharmacology / Q000627:therapeutic use; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D011957:Receptors, Opioid / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D055502:Secondary Prevention; D013654:Taurine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D000427:Alcohol Deterrents; D004723:Endorphins; D017448:Receptors, Dopamine D2; D011957:Receptors, Opioid; D013654:Taurine; D000431:Ethanol; D009271:Naltrexone; D000077443:Acamprosate